Sandu Pharmaceuticals Issues KYC and Demat Compliance Notice to Physical Shareholders
Sandu Pharmaceuticals Ltd 路 Others (Uncategorized) 路 30 Sept 2026, 5:48 pm
Sandu Pharmaceuticals Issues KYC and Demat Compliance Notice to Physical Shareholders Sandu Pharmaceuticals has dispatched reminder notices on 29th Sep'26 to physical security holders to submit mandatory PAN, KYC, bank account, and signature details to its RTA, MUFG Intime India Private Limited. Failure to provide complete information restricts dividend payouts exclusively to electronic mode post-1st Apr'24. Additionally, the company highlighted SEBI's one-year special re-lodgement window for defective pre-Apr'19 transfer deeds, operational from 5th Feb'26 to 4th Feb'27, under which processed shares will be issued solely in dematerialized form.
Original exchange filing (PDF)
More announcements from Sandu Pharmaceuticals Ltd
- statement of deviation and variation of funds for q ended 30th sept 2026 路 15 Nov 2026
- Results for Q and half year ended 30th sept 2026 路 15 Nov 2026
- Outcome of the Board Meeting dated 14th November 2026 路 15 Nov 2026
- Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Approval of Unaudited .... 路 14 Nov 2026
- Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta 路 09 Oct 2026
- 1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director 路 12 Sept 2026
- Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting 路 12 Sept 2026
- 41st Annual General Meeting scrutinizers Report 路 12 Sept 2026
